- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a target name.
BioCentury | Jun 6, 2020
Translation in Brief
Engineered bacteria for targeted bacterial killing; plus Cas12a base editors, base editing to restore hearing and more
BioCentury’s roundup of preclinical news
BioCentury | Oct 13, 2018
Product Development
Trevena goes for MOR than morphine
A mixed panel on oliceridine could leave the door open for collecting more data
BioCentury | Jan 9, 2018
Preclinical News
Selective kappa opioid receptor agonist could dial out side effects
BioCentury | Oct 28, 2013
Finance
Hoping to give thanks
Dynamics that will shape biotech IPO window leading into Thanksgiving break
Items per page:
1 - 10 of 12